Clinical Trial Update: 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial evaluates a Ga-68 labeled exendin-4 PET/CT agent for localizing insulinomas and diagnosing nesidioblastosis. The study status is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulinoma
• Nesidioblastosis

Drugs mentioned

• 68Ga-NOTA-exendin-4 PET/CT (exendin-4)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Insulinoma, Nesidioblastosis | EARLY_Phase 1 | Status: UNKNOWN